Share

CLINICAL TRIAL SEARCH RESULTS

NEW SEARCH
 Number: 201208091 Principal Investigator: Figenshau, R. Sherburne
Title: Evaluation of the Off-Clamp Robot-Assisted Partial Nephrectomy Technique in the Management of Renal Tumors
Description: A technique where the laparoscopic/robotic kidney surgery is performed without clamping of the blood vessels and without the interruption of the blood flow to the kidney has been developed and is being routinely performed here by your surgeon. It remains unclear whether it is better for kidney func...MORE
___________________________________________________________________________________________________
 Number: CTSU SWOG S0931 Principal Investigator: Roth, Bruce
Title: EVEREST: EVErolimus for Renal Cancer Ensuing Surgical Therapy, a Phase III Study
Description: The purpose of this study is to see whether treatment with everolimus after surgery for kidney cancer will keep the cancer from returning better than surgery alone....MORE
___________________________________________________________________________________________________
 Number: CALGB E2810 Principal Investigator: Picus, Joel
Title: Randomized, Double-Blind Phase III Study of Pazopanib vs. Placebo in Patients with Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease Following Metastasectomy
Description: The purpose of this study is to determine whether taking an oral drug known as pazopanib will reduce the risk of the cancer recurring in the future....MORE
___________________________________________________________________________________________________
 Number: CALGB A031203 Principal Investigator: Picus, Joel
Title: Randomized Phase II Study Comparing Cabozantinib (NSC #761968 and IND #116059) with Commercially Supplied Sunitinib in Patients with Previously Untreated Locally Advanced or Metastatic Renal Cell Carcinoma
Description: The purpose of this study is to find out what effects, good and/or bad, two study drugs called sunitinib and cabozantinib have on advanced or metastatic kidney cancer....MORE
___________________________________________________________________________________________________
 Number: 201301006 Principal Investigator: Roth, Bruce
Title: An International Phase 3, Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS-003) plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)
Description: The purpose of this research study is to see if treatment with AGS-003 (a drug made using a piece of a patient's tumor and a patient's own white blood cells) plus regular medications is any different than treatment with regular medications alone....MORE
___________________________________________________________________________________________________
 Number: 201201112 Principal Investigator: Lockhart, A. Craig
Title: A Phase 1 First-in-Human Study Evaluating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 172 in Subjects with Relapsed / Refractory Renal Cell Carcinoma
Description: The purpose of this research study is to find out more about a study drug called AMG 172 in people with kidney cancer. The study will see if AMG 172 is safe in people who are 18 years of age or older and whether it causes any side effects. This study will also look at what doses of AMG 172 are safe ...MORE
___________________________________________________________________________________________________